Telix Pharmaceuticals Limited Increase Decrease Through Net Exchange Differences Other Provisions
Telix Pharmaceuticals Limited (TLPPF) reported Increase Decrease Through Net Exchange Differences Other Provisions of $1.21 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions · last filed 2026-02-20
AUD
| Period end | Increase Decrease Through Net Exchange Differences Other Provisions 12 month |
|---|---|
| 2024-12-31 | 455.00K AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 221.00K AUD 20-F · filed 2025-02-24 |
USD
| Period end | Increase Decrease Through Net Exchange Differences Other Provisions 12 month |
|---|---|
| 2025-12-31 | $1.21M 20-F · filed 2026-02-20 |
| 2024-12-31 | -$520.00K 20-F · filed 2026-02-20 |